Systematic reviews as a tool for planning and interpreting trials

International Journal of Stroke

Volumn 4, Issue 1, 2009, Pages 23-27

  Bath, Philip M W ^a   Gray, Laura J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Clinical trials; Epidemiology; Meta analysis; Stroke

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; CITICOLINE; CLOPIDOGREL; DIPYRIDAMOLE; ESTROGEN; GAVESTINEL; LOW MOLECULAR WEIGHT HEPARIN; LUBELUZOLE; MAGNESIUM; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE; PROGESTERONE; TIRILAZAD; WARFARIN;

CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; DECOMPRESSION SURGERY; DISEASE MODEL; DRUG EFFICACY; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; EXPERIMENTAL STUDY; HEALTH CARE PLANNING; HUMAN; INTERVENTION STUDY; META ANALYSIS; METHODOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; REVIEW LITERATURE AS TOPIC; STROKE;

EID: 60549094065     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00235.x     Document Type: Review

References (40)

1. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E: Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003.
2. The ATLANTIS ECASS and NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-813.
3. Gubitz G, Sandercock P, Counsell C: Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003.
4. Stroke Unit Trialists' Collaboration: Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2002.
5. Vahedi K, Hofimeijer J, Vacaut E et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215-22.
6. Lees KR, Muir KW: Excitatory Amino Acid Antagonists for Acute Stroke (Cochrane Review). The Cochrane Library. In press ed. Oxford: Update Software, 2002.
7. Gubitz G, Counsell C, Sandercock P: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004.
8. Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension 2004; 43: 18-24.
9. Sandercock P, Roberts I: Systematic reviews of animal experiments. Lancet 2002; 360: 586.
10. Stroke Therapy Academic Industry Roundtable (STAIR): Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30: 2752-8.
11. Horn J, deHaan R, Vermeulen M, Luiten PGM, Limburg M: 2045. Nimodipine in animal model experiments of focal cerebral ischemia. Stroke 2001; 32: 2433-8.
12. Horn J, Limburg L, Orgogozo JM: Calcium Antagonists for Acute Ischemic Stroke. The Cochrane Library, 1st edn. Oxford: Update Software, 2001.
13. Willmot M, Gray L, Gibson C, Murphy S, Bath PMW: Systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 2005; 12: 141-9.
14. The ENOS Trial Investigators: Glyceryl trinitrave vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006; 1: 245-9.
15. Macleod MR, O'Collins T, Howells DW, Donnan GA: Pooling of animal experimental data reveals influence of study design and publications bias. Stroke 2004; 35: 1203-8.
16. Sacco RL, DeRosa JT, Haley EC et al. Glycine antagonist in neuroprotection for patients with acute stroke. GAIN Americas: A randomized controlled trial. J Am Med Assoc 2001; 285: 1719-28.
17. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): Randomised controlled trial. Lancet 2004; 363: 439-45.
18. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke. A randomised, double-blind, placebo-controlled, dose-escalation study. Stroke 2000; 31: 601-9.
19. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators: Emergency treatment of Abciximab for treatment of patients with acute ischemic stroke. Results of a randomized phase 2 trial. Stroke 2005; 36: 880-90.
20. Adams HP, Effron MB, Torner J et al. Emergency administration of abciximab for the treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008; 39: 87-99.
21. Leonardi-Bee J, Bath PM, Bousser MG et al. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: A meta-analysis of individual patient data from randomized controlled trials. Stroke 2005; 36: 162-8.
22. Gandolfo C, Sandercock P, Conti M: Lubeluzole for acute ischaemic stroke. Cochrane Database Syst Rev 2002.
23. Davis SM, Lees KR, Albers GW et al. Selfotel in acute ischemic stroke. Possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31: 347-54.
24. Davalos A, Castillo J, Alvarez-Sabin J et al. Oral citicoline in acute ischemic stroke. An individual patient data pooling analysis of clinical trials. Stroke 2002; 33: 2850-7.
25. Whiteley W, Lindley R, Wardlaw J, Sandercock P, on behalf of the IST-3 Collaborative Group: Third International Stroke Trial. Int J Stroke 2006; 1: 172-6.
26. Bath PMW, Bath FJ: Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. Cochrane Database of Syst Rev 2004.
27. Bath PMW, Iddenden R, Bath FJ: Low-molecular-weight heparins and heparinoids in acute ischemic stroke - a meta-analysis of randomized controlled trials. Stroke 2000; 31: 1770-8.
28. Bath P, Lindenstrom E, Boysen G et al. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial. Lancet 2001; 358: 702-10.
29. Bath PM, Iddenden R, Bath FJ, Orgogozo JM; Tirilazad International Steering Committee. Tirilazad for acute ischaemic stroke. Cochrane Database Syst Rev 2001; (4): CD002087.
30. Graham GD: Tissue plasminogen activator for acute ischemic stroke in clinical practice: A meta analysis of safety data. Stroke 2003; 34: 2847-50.
31. Stewart LA, Parmar MK: Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet 1993; 341: 418-22.
32. Staessen JA, Li Y, Thijs L, Want J-G: Blood pressure reduction and cariovascular prevention: An update including the 2003-2004 secondary prevention trials. Hypertens Res 2005; 28: 385-407.
33. Willmot M, Gibson C, Gray L, Murphy S, Bath PMW: Nitric oxide synthase inhibitors in experimental stroke and their effects on infarct size and cerebral blood flow; a systematic review. Free Rad Biol Med 2005; 39: 412-25.
34. Song F, Altman DG, Glenny A-M, Deeks JJ: Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. Br Med J 2003; 326: 472-7.
35. Testa L, Zoccai GB, Porto I et al. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes. Am J Cardiol 2007; 99: 1637-42.
36. Sare GM, Gray LJ, Bath PWM: Association between hormone replacement therapy and subsequent arterial and venous vascular events: A meta analysis. Eur Heart J 2008; 29: 2031-41.
37. The Optimising Analysis of Stroke Trials (OAST) Collaboration: Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials. Stroke 2007; 38: 1911-5.
38. The Optimising Analysis of Stroke Trials (OAST) Collaboration, Gray LJ, Bath PMW, Collier T: Calculation of samples size for stroke trials assessing functional outcome: Comparison of binary and ordinal approaches. Int J Stroke 2008; 3: 78-84.
39. Bath PMW, Geeganage C, Gray LJ, Collier T, Pocock S: Optimising the analysis of stroke prevention trials: Converting dichotomous vascular outcomes into ordinal measures. Stroke 2008; 39: 2817-23.
40. Whitehead A, Omar RZ, Higgins JPT, Savaluny E, Turner RM, Thompson SG: Meta-analysis of ordinal outcomes using individual patient data. Stat Med 2001; 20: 2243-60.